These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19499416)

  • 1. Hyperandrogenism in oligomenorrhoea with minimal or nil 'unwanted hair growth'.
    Bhattacharya SM
    Gynecol Endocrinol; 2009 Jul; 25(7):423-6. PubMed ID: 19499416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlations between clinical signs and hormonal parameters in young women with hirsutism].
    Kristesashvili J; Chanukvadze D
    Georgian Med News; 2011 Nov; 11(200):30-5. PubMed ID: 22201077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of different diagnostic methods for assessment of hyperandrogenism in young women with hirsutism.
    Chanukvadze D; Kristesashvili J
    Georgian Med News; 2011 Nov; 11(200):25-9. PubMed ID: 22201076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrinological markers for assessment of hyperandrogenemia in hirsute women.
    Mueller A; Cupisti S; Binder H; Hoffmann I; Kiesewetter F; Beckmann MW; Dittrich R
    Horm Res; 2007; 67(1):35-41. PubMed ID: 17019078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.
    Loverro G; Lorusso F; De Pergola G; Nicolardi V; Mei L; Selvaggi L
    Gynecol Endocrinol; 2002 Jun; 16(3):217-24. PubMed ID: 12192894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of androgen excess among patients with minimal unwanted hair growth.
    Souter I; Sanchez LA; Perez M; Bartolucci AA; Azziz R
    Am J Obstet Gynecol; 2004 Dec; 191(6):1914-20. PubMed ID: 15592272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
    Mitkov M; Pehlivanov B; Terzieva D
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):93-8. PubMed ID: 16360262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
    Pakarinen P; Lähteenmäki P; Rutanen EM
    Acta Obstet Gynecol Scand; 1999 May; 78(5):423-8. PubMed ID: 10326889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and menstrual irregularity: associations with SHBG, testosterone, and insulin.
    Wei S; Schmidt MD; Dwyer T; Norman RJ; Venn AJ
    Obesity (Silver Spring); 2009 May; 17(5):1070-6. PubMed ID: 19180069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex hormone binding globulin decrease as a potential pathogenetic factor for hirsutism in adolescent girls.
    Cross G; Danilowicz K; Kral M; Caufriez A; Copinschi G; Bruno OD
    Medicina (B Aires); 2008; 68(2):120-4. PubMed ID: 18499959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone.
    Mueller A; Dittrich R; Cupisti S; Beckmann MW; Binder H
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):182-7. PubMed ID: 16705550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The diagnostic value of serum hormone parameters in hirsutism].
    Carol W; Börner A; Wilke I; Starker W; Michels W
    Zentralbl Gynakol; 1992; 114(10):502-8. PubMed ID: 1329402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B; Slopien R; Warenik-Szymankiewicz A
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.
    Lello S; Primavera G; Colonna L; Vittori G; Guardianelli F; Sorge R; Raskovic D
    Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study.
    Golden SH; Ding J; Szklo M; Schmidt MI; Duncan BB; Dobs A
    Am J Epidemiol; 2004 Sep; 160(6):540-8. PubMed ID: 15353414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.